Cervical cancer is a major cause of morbidity and mortality worldwide. It is the fourth most frequently diagnosed cancer in women worldwide, and the second most in developing countries.
The death toll is greatest in populations that lack cervical cancer screening programmes., with over 90% of cervical cancer related death occurring in low & middle-income countries. If early changes in cervical cells are detected through screening programmes, cervical cancer is preventable. However, if undetected until late in its clinical course, it has a high mortality rate.
Cervical cancer is a major cause of morbidity and mortality worldwide. It is the second largest cause of deaths due to cancer in women.
Cervical cancer develops from slowly progressing intraepithelial lesions. If early changes in cervical cells are detected through screening programmes, cervical cancer is curable.
TruScreen is a new technology used to detect pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue.
Cervical screening in Australia has been successful in reducing the incidence and mortality of cervical cancer.
Learn more about how cervical cancer develops and what the risk factors are for this disease that kills more than 270,000 women every year.